Rare expression of T-cell markers in classical Hodgkin's lymphoma

@article{Tzankov2005RareEO,
  title={Rare expression of T-cell markers in classical Hodgkin's lymphoma},
  author={Alexandar Tzankov and Caroline Bourgau and Alexandra Kaiser and Annette Zimpfer and Robert Maurer and Stefano Aldo Pileri and Philip Th Went and Stephan Dirnhofer},
  journal={Modern Pathology},
  year={2005},
  volume={18},
  pages={1542-1549}
}
Hodgkin's and Reed–Sternberg cells of classical Hodgkin's lymphoma are primarily of B-cell origin, although there are instances of T-cell antigen expression suggesting T-cell origin. We comprehensively analyzed expression of various T-cell antigens in 259 classical Hodgkin's lymphoma cases using the tissue microarray technique. Expression of the T-cell antigens CD2, CD3, CD4, CD5, CD7 and CD8 was assessed by immunohistochemistry. Hodgkin's and Reed–Sternberg cells of T-cell marker-positive… Expand
Classical Hodgkin Lymphoma With Aberrant CD8 Expression: A Clinicopathologic Study of Five Cases
TLDR
5 cases of Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma with aberrant CD8 expression are identified and T-cell receptor genes are revealed to be in germline configuration in 4 cases with available information. Expand
Gene rearrangement and comparative genomic hybridization studies of classic Hodgkin lymphoma expressing T-cell antigens.
TLDR
The findings suggest that a T-cell phenotype classic Hodgkin lymphoma can be supported by genotypic studies and that there may be cytogenetic differences between classic Hodgkins lymphoma and Hodgkinymphoma expressing T- cell antigens. Expand
PAX5-positive T-cell Anaplastic Large Cell Lymphomas Associated with Extra Copies of the PAX5 Gene Locus
TLDR
It is concluded that aberrant expression of PAX5 occurs rarely in T-cell anaplastic large cell lymphomas, and may be associated with extra copies of the PAX5 gene. Expand
Prognostic significance of T-cell or cytotoxic molecules phenotype in classical Hodgkin's lymphoma: a clinicopathologic study.
TLDR
The presence of T-cell and/or cytotoxic antigens in H-RS cells may represent a poor prognostic factor in CHL, even if their expression is not regarded as lineage specific. Expand
Classical Hodgkin Lymphoma with Positive Epstein-Barr Virus Status is Associated with More FOXP3 Regulatory T Cells
TLDR
EBV status has an impact on composition of T cell populations in the cHL microenvironment, with special emphasis on Treg in regard to Epstein-Barr virus (EBV) status, subtype, and patient age. Expand
Clinicopathologic Features of B-Cell Lineage Neoplasms With Aberrant Expression of CD3: A Study of 21 Cases
TLDR
The spectrum of morphologic, phenotypic, and clinical features of B-cell neoplasms aberrantly expressing CD3 are expanded, and DLBCLs with anaplastic features and the single follicular lymphoma coexpressed multiple T-cell antigens in a predominantly membranous pattern and presented with nodal disease in a relatively younger patient population. Expand
Peripheral T-cell lymphoma with aberrant expression of CD30, CD15, and CD20.
TLDR
This case highlights pitfalls in the accurate diagnosis of PTCL as the expression of CD20 might lead one to suspect a B-cell neoplasm, whereas the expressionof CD30 and CD15 point toward diagnosis of classical Hodgkin’s lymphoma (cHL). Expand
Nodal Involvement by Cutaneous CD30-positive T-cell Lymphoma Mimicking Classical Hodgkin Lymphoma
TLDR
It is shown that cHL is less often associated with MF and primary cutaneous CD30-T-LPD than previously thought and that the coexpression of CD30 and CD15 in these TCLs may lead to a mistaken diagnosis of cHL. Expand
Use of an expanded immunohistochemical panel to distinguish cutaneous Hodgkin lymphoma from histopathologic imitators
TLDR
A 40‐year‐old man with classical Hodgkin lymphoma who developed cutaneous nodules is reported, the first report of the expression pattern of the combination of PAX5, Oct‐2 and BOB.1 in the context of cutaneous involvement by Hodgkinymphoma. Expand
CD3-positive plasmablastic B-cell neoplasms: a diagnostic pitfall
TLDR
It is emphasized that the accurate classification of CD3+ plasmablastic neoplasms requires thorough morphologic examination, incorporation of more B-cell and T-cell markers in addition to CD3 and CD20, frequent addition of CD138 staining, and utilization of necessary molecular and genetic studies. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 56 REFERENCES
Expression of B-Cell Markers in Classical Hodgkin Lymphoma: A Tissue Microarray Analysis of 330 Cases
TLDR
Assessment of expression of the B-cell–related antigens CD20, CD79a, and CD138 in classical Hodgkin lymphoma using a tissue microarray using a sample of 330 cases concluded that B- cell markers are expressed in 38% of classical Hodgkins lymphoma. Expand
Aberrant expression of T-cell-associated antigens on B-cell non-Hodgkin lymphomas.
TLDR
9 well-characterized cases of B-cell non-Hodgkin lymphoma that showed aberrant expression of T-cell-associated antigens by 2-color flow cytometry are described and may prove invaluable to study aberrant activation of silent or repressed T- cell differentiation genes. Expand
T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma.
TLDR
It is found that neoplastic cells in most cases of classic Hodgkin's lymphoma, including nodular sclerosis type and mixed cellularity type, express T-bet, a T-box transcription factor that may play a role in Hodgkin’s lymphoma oncogenesis. Expand
Correlation between presence of clonal rearrangements of immunoglobulin heavy chain genes and B-cell antigen expression in Hodgkin's disease.
TLDR
Results show that PCR represents a specific and sensitive technique for the detection of IgH gene rearrangements in cases of Hodgkin's disease and suggest a lymphoid B-cell derivation of HRS cells in a high proportion of the cases. Expand
The expression of the CD3 antigen in Hodgkin's disease
TLDR
It appears that some Hodgkin and Reed‐Sternberg cells can express the major T‐cell antigen CD3, consistent with the hypothesis that at least some cases of Hodgkin's disease arise from activated T‐cells. Expand
Detection of clonal T-cell receptor gamma-chain gene rearrangements in Reed-Sternberg cells of classic Hodgkin disease.
TLDR
It is concluded that cases of classic HD with T-cell-derived HRS cells definitely exist, although their overall incidence is very low, and even within the T- cell marker-positive cases only a minority were derived from T cells. Expand
Expression of lymphoid‐associated antigens on Hodgkin's and Reed‐Sternberg cells of Hodgkin's disease. An immunocytochemical study on lymph node cytospins using monoclonal antibodies
TLDR
A lymphoid (either T or B) rather than histiocytic origin for the Hodgkin's and Reed‐Sternberg cells in a number of Hodgkin’s disease cases is suggested. Expand
Rare Occurrence of Classical Hodgkin's Disease as a T Cell Lymphoma
TLDR
In two cases of cHD with H/RS cells expressing cytotoxic T cell molecules, the tumor cells are derived from mature B cells that aberrantly express T cell markers, demonstrating that cHD can also occur as a T cell lymphoma. Expand
Molecular biology of Hodgkin's lymphoma.
  • R. Küppers
  • Biology, Medicine
  • Advances in cancer research
  • 2002
TLDR
Significant progress has been made in the understanding of the cellular interactions in HL tissues, which are mainly mediated by a large variety of cytokines and chemokines, andConstitutive activation of the transcription factor NFkappaB, which can be induced through Epstein-Barr virus transformation of HRS cells or destructive somatic mutations of the inhibitor of NFkappyB, is likely to be a key event in HL pathogenesis. Expand
Granzyme B expression in Reed-Sternberg cells of Hodgkin's disease.
TLDR
It is concluded that in a restricted number of cases of Hodgkin's disease, the H-RS cells express granzyme B, and therefore might be considered the neoplastic equivalent of either activated CTLs or NK cells. Expand
...
1
2
3
4
5
...